Keynote speaker
President & Chief Executive Officer, Artiva Biotherapeutics, Inc
Fred Aslan, President & Chief Executive Officer at Artiva Biotherapeutics, Inc, is a keynote speaker at 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026) in the session “Deep B-Cell Depletion: Evolution From Early Proof-of-Concept To Registrational Trials”.
1–3 Dec 2026Philadelphia, United States of America
Executive Director, Preclinical Development, Moderna
Vice President, Immunology, Sail Biomedicines
Chief Business Development Officer, PolTREG
Co-Founder & Chief Executive Officer, Overland Therapeutics
Chief Medical Officer, GentiBio
Chief Science & Technical Officer, Quell Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Fred Aslan, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].